宿州亿帆药业

Suzhou Yifan Pharmaceutical Co., Ltd. (宿州亿帆药业有限公司) is a China-based pharmaceutical manufacturing company and a wholly owned subsidiary of Yifan Pharmaceutical Co., Ltd. (002019.SZ). Founded in 2013 and located in Suzhou, Anhui Province, the company operates as a major production base for traditional Chinese medicine (TCM) extraction, small molecule active pharmaceutical ingredients (APIs), and finished dosage forms. Its extensive manufacturing capabilities include 12 API production lines and 21 preparation lines covering tablets, capsules, granules, oral liquids, and topicals. The company's product portfolio and pipeline span multiple therapeutic areas, including oncology, endocrinology, dermatology, and gastroenterology, with recent developments in generic formulations such as melatonin granules and glycerol phenylbutyrate.